<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Thoughts — Human Artificial Chromosomes</title>
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="container">
        <section class="section">
            <p><a href="index.html">← All thoughts</a></p>
            <h1>Human Artificial Chromosomes</h1>
            <p class="post-meta">Published 2025-09-13</p>
            <div class="post-content"><h1>Human Artificial Chromosomes</h1>

<p>As genetic modification becomes scalable, there are two broad ways to change human biology: germline and somatic. Germline edits happen at the embryo stage (for example with IVF plus CRISPR) so every cell carries the same change. Somatic edits happen in existing tissues and usually rely on delivering &quot;genetic circuits&quot; that control when a gene turns on and off.</p>

<p>For somatic work, delivery usually means viruses that prefer certain tissues. AAV is popular for small payloads, with a practical packaging limit around 4.7 kilobases. Lentivirus carries about 8 to 10 kilobases. Adenovirus helper-dependent vectors can carry roughly 30 to 36 kilobases. The biggest viral delivery system is based on HSV, which can deliver on the order of 150 kilobases. These are useful numbers, but they cap what you can deliver in one shot.</p>

<p>A <strong>shared scaffold</strong> becomes important as somatic therapies multiply. Over a lifetime, a person may receive many tissue-targeted payloads: repairs, interfaces, sensors, and performance programs. Without a common scaffold, each payload rebuilds control logic, insulation, and coexistence rules. A shared scaffold standardizes promoters, insulators, addressable landing pads, and scheduling so independent programs can run side by side without cross talk. If upgrades become routine, should the body have a single safe slot for all future payloads?</p>

<p>A <em>human artificial chromosome (HAC)</em> is a synthetic, human-like chromosome that lives in the nucleus as an <em>episome</em>. It replicates with the cell cycle and segregates during mitosis because it includes centromeric DNA and telomere sequences. That means it does not integrate into native chromosomes, and it does not drift away over time the way simple plasmids often do. In cell lines, HACs have been maintained for hundreds of divisions with stable copy number.</p>

<p>The mental model is a <strong>DNA chip inside the cell</strong>. One HAC can host many programs (for example Tet-On circuits controlled by doxycycline) that you can switch on or off as needed. You add, update, and remove cassettes on the HAC without touching the underlying genome.</p>

<p>Capacity is another reason HACs matter. Synthetic HACs are typically 1 to 10 megabases, two to three orders of magnitude larger than HSV-based vectors. That space lets you co-locate longevity pathways (for example DNA repair or telomere maintenance), performance programs (for example muscle hypertrophy), and interface modules for hardware (for example optogenetic channels or engineered receptors for neural implants, prosthetics, or wearable devices) on one substrate. Each program runs in its own channel with its own on/off switch and insulation. A key on-HAC device for the future is the <em>molecular recorder</em>, which logs cellular events in tissues and outputs timestamped RNA signatures into the blood for continuous, longitudinal health monitoring.</p>

<p><strong>The catch is delivery.</strong> A megabase-scale HAC does not fit inside any current human-infective virus. Today, HACs are introduced with lab methods like microcell-mediated chromosome transfer or cell fusion, which are not yet suitable for use across an entire body.</p>

<p>A practical path likely has two parts. First, define the <em>minimal effective basespace for a HAC</em> that preserves stable episomal maintenance and faithful segregation. This compact core would include a synthetic centromere (for example alphoid DNA with CENP-B boxes), telomeric repeats, insulators, and a few landing pads for later cassette insertion. The target size should be below about 120 to 150 kilobases so that it can be delivered as a single unit.</p>

<p>Second, engineer <em>the largest human-infective double-stranded DNA virus</em> that can carry the entire HAC in one capsid. HSV-1 amplicon vectors package on the order of 150 kilobases, and HCMV-derived systems offer similar or greater headroom. Double-stranded DNA viruses tolerate large genomes and deliver DNA directly to the nucleus, which aligns with HAC establishment requirements. The vector would need appropriate packaging signals and a release path that yields a single circular molecule that establishes the centromere and telomeres in the nucleus. For targeted delivery into the body, capsid pseudotyping can display tissue-trophic proteins or ligands on the viral surface to bias infection toward the intended organ or cell type. <em>Single-piece delivery</em> reduces assembly errors, lowers in vivo recombination load, and improves copy number control.</p>

<p>If we can meet these two conditions, HACs give somatic engineering a clean separation of concerns. </p>

<p><strong>The native genome stays untouched</strong>, and complex functionality lives on a modular, maintainable, synthetic and removable episome.</p></div>
        </section>
    </div>
</body>
</html>
